Company | Gen Digital Inc. |
Ticker | GEN (NASDAQ) |
Reporting Period | Q1 FY2027 (quarter ending June 30, 2026) |
Earnings Date | August 6, 2026 (after market close) |
Prepared | August 5, 2026 |
Key Takeaway: The setup into Q1 FY2027 is modestly constructive — consensus sits at the midpoint of guidance, GEN has beaten EPS in each of the last four quarters with an average surprise of ~3%, and the stock has re-rated +38% since the May 7 print, leaving limited room for a multiple-driven pop but a solid fundamental beat could still drive upside. The single biggest swing factor is MoneyLion revenue trajectory and whether the Engine marketplace can sustain the momentum that drove partner revenue to a near-$1B run rate.
Heading into Q1 FY2027, the bar is achievable but not low: consensus revenue of ~$1.31B sits at the midpoint of the $1.30–$1.325B guidance range, and EPS consensus of $0.69 is also at the midpoint of the $0.68–$0.70 guide, implying the Street is not pricing in a meaningful beat. Management's posture on the May 7 call was notably more confident than prior quarters — the FY2027 revenue growth outlook was raised to 8–10% (from a prior mid-single-digit target), net leverage hit 3x EBITDA a year ahead of schedule, and the xAI partnership and OpenAI Trusted Access for Cyber announcements signaled accelerating AI-native product momentum. Estimate revisions have been essentially flat since the post-earnings baseline (EPS consensus moved from $0.690 to $0.690, revenue from $1.315B to $1.314B), suggesting the Street has largely digested the raised guide without adding incremental cushion. The stock has outperformed the cybersecurity ETF (BUG) and the S&P 500 since the last print (+38% vs. +41% for BUG and +5% for SPY), meaning GEN has broadly kept pace with the sector re-rating driven by the AI security demand surge. The key wildcard is MoneyLion's Q1 growth rate: if it sustains near the ~40% pace seen in Q4 FY2026 rather than decelerating toward the guided 30% exit rate, that alone could drive a meaningful revenue beat and force upward revisions to the FY2027 $1.12B MoneyLion revenue estimate.
Key Takeaway: Consensus is a moderate bar — estimates sit at the midpoint of guidance across all key metrics, leaving room for a beat if MoneyLion and partner revenue continue to outperform. MoneyLion revenue and partner revenue are the bigger swing factors; both have consistently beaten consensus by wide margins in recent quarters.
KPI | Q4 FY2026 Actual | Q1 FY2026 Actual (Prior Year) | Q1 FY2027 Consensus Estimate | YoY Change | Q1 FY2027 Guidance | Consensus vs. Guidance Midpoint |
Net Revenue (Operating) | $1,283M | $1,257M | $1,314M | +4.5% YoY | $1,300–$1,325M | -0.1% (at midpoint) |
EPS — Diluted (Operating) | $0.67 | $0.64 | $0.69 | +7.8% YoY | $0.68–$0.70 | 0.0% (at midpoint) |
Operating Income (Operating) | $641M | $650M | $652M | +0.3% YoY | N/A (not guided separately) | N/A |
MoneyLion Revenue | $233M | $168M | $269M | +60% YoY | N/A (not guided separately) | N/A |
Partner Revenue | $127M | $168M | $193M | +15% YoY | N/A (not guided separately) | N/A |
Cyber Safety Revenue | $837M | $869M | $847M | -2.5% YoY | Mid-single-digit growth (segment) | N/A |
Direct Customers | 41.87M | 40.60M | 42.00M | +3.5% YoY | N/A | N/A |
Direct ARPU (monthly) | $7.50 | $7.25 | $7.52 | +3.7% YoY | N/A | N/A |
Direct Customer Retention Rate | 78.7% | 77.7% | 78.8% | +110 bps YoY | N/A | N/A |
Free Cash Flow | $449M | $410M | $332M | -19% YoY | N/A | N/A |
Source: Visible Alpha Consensus and Actuals Data. All figures in USD. Q1 FY2027 = quarter ending June 30, 2026. Q1 FY2026 = quarter ending June 30, 2025. Note: MoneyLion revenue consensus of $269M implies ~60% YoY growth vs. $168M in Q1 FY2026; partner revenue consensus of $193M implies ~15% YoY growth. Cyber Safety revenue YoY comparison reflects the Q1 FY2026 actual of $869M which included a large one-time partner contribution; underlying segment growth guidance is mid-single digits.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q4 FY2026 | Net Revenue | $1,283M | $1,250M | +2.7% | Beat |
Q4 FY2026 | EPS (Diluted, Op.) | $0.67 | $0.65 | +3.1% | Beat |
Q3 FY2026 | Net Revenue | $1,240M | $1,230M | +0.8% | Beat |
Q3 FY2026 | EPS (Diluted, Op.) | $0.64 | $0.63 | +1.6% | Beat |
Q2 FY2026 | Net Revenue | $1,220M | $1,195M | +2.1% | Beat |
Q2 FY2026 | EPS (Diluted, Op.) | $0.62 | $0.61 | +1.6% | Beat |
Q1 FY2026 | Net Revenue | $1,257M | $1,186M | +6.0% | Beat |
Q1 FY2026 | EPS (Diluted, Op.) | $0.64 | $0.60 | +6.7% | Beat |
Q4 FY2025 | Net Revenue | $1,010M | $997M | +1.3% | Beat |
Q4 FY2025 | EPS (Diluted, Op.) | $0.59 | $0.58 | +1.7% | Beat |
Q3 FY2025 | Net Revenue | $986M | $985M | +0.1% | Beat |
Q3 FY2025 | EPS (Diluted, Op.) | $0.56 | $0.55 | +1.8% | Beat |
Q2 FY2025 | Net Revenue | $974M | $970M | +0.4% | Beat |
Q2 FY2025 | EPS (Diluted, Op.) | $0.54 | $0.54 | 0.0% | In-Line |
Q1 FY2025 | Net Revenue | $965M | $964M | +0.1% | Beat |
Q1 FY2025 | EPS (Diluted, Op.) | $0.53 | $0.53 | 0.0% | In-Line |
Source: Visible Alpha Consensus and Actuals Data. Pattern: GEN has beaten or matched consensus on both revenue and EPS in each of the last 8 quarters, with the largest beats occurring in Q1 FY2026 (+6.0% revenue, +6.7% EPS) when MoneyLion was first consolidated; more recent beats have been smaller (1–3%) as the Street has caught up to the MoneyLion contribution, suggesting the bar is now more accurately set.
Key Takeaway: Guidance has not been formally revised since the May 7 earnings call, but management's tone was materially more confident — the FY2027 revenue growth outlook was raised to 8–10% (from a prior mid-single-digit target), representing a structural step-change. No post-earnings 8-K or conference update has changed the numbers; the May 7 guide remains the baseline.
Metric | Initial Guidance (May 7, 2026 Earnings Call) | Revised Guidance | Current Consensus | Note |
Q1 FY2027 Revenue | $1,300M – $1,325M (8–10% pro forma growth) | — | $1,314M | Unchanged; consensus at midpoint of range |
Q1 FY2027 EPS (Non-GAAP) | $0.68 – $0.70 (13–17% pro forma growth) | — | $0.69 | Unchanged; consensus at midpoint of range |
FY2027 Revenue | $5,325M – $5,425M (8–10% pro forma growth) | — | $5,378M | Unchanged; consensus slightly above midpoint ($5,375M) |
FY2027 EPS (Non-GAAP) | $2.85 – $2.95 (13–17% pro forma growth; 15% at midpoint) | — | $2.89 | Unchanged; consensus slightly below midpoint ($2.90) |
Operating Margin (Overall) | ~50% (stable; CS at 61%, TBS at 30%) | — | N/A — not separately tracked in VA | Management guided stable margins; no change expected |
Revenue Synergies (Incremental) | >$100M incremental annual revenue from embedded financial wellness, partner expansion, and Engine growth beginning H2 FY2027 | — | N/A | First quantified synergy target; scaling into FY2028–FY2029 |
Source: GEN Q4 FY2026 Earnings Call Transcript (May 7, 2026); Visible Alpha Consensus and Actuals Data. No post-earnings guidance revisions have been filed via 8-K or announced at conferences. The $50M restructuring program announced May 7 is an operational initiative and does not change revenue or EPS guidance.
Key Takeaway: Estimates have been essentially flat since the post-earnings baseline, tracking guidance almost exactly — there is no meaningful divergence between consensus and the guidance midpoint on either revenue or EPS. The lack of upward revision despite strong Q4 beats and a raised FY2027 outlook suggests the Street is in a wait-and-see mode, creating potential for positive revision momentum if Q1 delivers another beat.
KPI & Period | Estimate (5 Days Post May 7 Earnings) | Current Consensus | Estimate Δ (%) | Initial Guidance (May 7 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Net Revenue — Q1 FY2027 | $1,315M | $1,314M | -0.1% | $1,300–$1,325M (mid: $1,313M) | Unchanged | — | +0.1% vs. midpoint |
EPS (Diluted, Op.) — Q1 FY2027 | $0.690 | $0.690 | 0.0% | $0.68–$0.70 (mid: $0.69) | Unchanged | — | 0.0% vs. midpoint |
Net Revenue — FY2027 | $5,379M | $5,378M | 0.0% | $5,325–$5,425M (mid: $5,375M) | Unchanged | — | +0.1% vs. midpoint |
EPS (Diluted, Op.) — FY2027 | $2.893 | $2.893 | 0.0% | $2.85–$2.95 (mid: $2.90) | Unchanged | — | -0.2% vs. midpoint |
MoneyLion Revenue — FY2027 | $1,123M | $1,123M | 0.0% | N/A (not guided separately) | N/A | — | N/A |
Partner Revenue — FY2027 | $664M | $784M | +18.1% | N/A (not guided separately) | N/A | — | N/A |
Source: Visible Alpha Consensus and Actuals Data; GEN Q4 FY2026 Earnings Call Transcript (May 7, 2026). The notable exception is partner revenue for FY2027, where the current consensus of $784M is 18% above the as-of-May-12 baseline of $664M — reflecting the Street's upward revision following Q4's 78% reported partner revenue growth and the confirmation that the Investor Day target had been surpassed. This is the one area where estimates have moved materially above the initial post-earnings baseline.
Key Takeaway: GEN has gained +38% since the May 7 earnings print, broadly in line with the cybersecurity sector (BUG ETF +41%) and well ahead of the S&P 500 (+5%), suggesting the move has been sector-driven by the AI security demand surge (the ‘Mythos’ inflection) rather than GEN-specific fundamental re-rating. The stock peaked near $28 in early August ahead of the Q1 print.
GEN vs. BUG (Cybersecurity ETF) vs. S&P 500 — Indexed to 100 at May 7, 2026 (Q4 FY2026 Earnings). Source: Stock Price Data.
Key Takeaway: The most important development since the May 7 earnings call is the $50M AI-driven restructuring program approved by the Board, which signals management is actively reinvesting efficiency gains into strategic priorities — a positive for long-term margin durability but a near-term cost headwind to watch in Q1 FY2027 results.
Key Takeaway: Enterprise cybersecurity peers (CRWD, PANW, FTNT, CHKP) are all reporting an AI-driven demand acceleration that is structurally positive for the cybersecurity category — a read-through tailwind for GEN’s cyber safety segment. The ‘Mythos’ inflection point cited by CrowdStrike and Palo Alto is driving elevated security spending that benefits the broader sector, though GEN’s consumer-focused model means the direct read-through is more thematic than operational.
Note: All peer commentary below is from earnings calls or investor events that occurred after GEN’s last earnings (May 7, 2026) and relates to the current reporting environment (calendar Q2 2026 / GEN’s Q1 FY2027 period). Commentary about prior-period results is excluded; only forward-looking commentary and current-quarter demand observations are included.
Read-Through Relevance: HIGH — CRWD’s commentary on AI-driven demand acceleration, identity protection growth, and the ‘Mythos’ inflection point is directly relevant to GEN’s cyber safety and identity protection segments.
Read-Through Relevance: MEDIUM — PANW’s commentary on AI-driven demand, identity security, and subscription trends is thematically relevant to GEN, though PANW is enterprise-focused.
Read-Through Relevance: MEDIUM — FTNT’s commentary on AI-driven demand, subscription trends, and pricing is relevant to GEN’s cyber safety segment, though FTNT is primarily a network security vendor.
Read-Through Relevance: LOW-MEDIUM — CHKP’s commentary is more cautionary, with product revenue declining 14% and Q3 expected to be a trough. However, subscription trends and AI demand commentary are relevant.
Peer | Event Date | Key Theme | GEN Read-Through | Signal |
CRWD | June 3, 2026 | AI demand surge (‘Mythos’); identity ARR 4x YoY; raised FY guidance +520 bps | Cyber safety & identity demand tailwind; subscription consolidation validates GEN’s platform strategy | Positive |
PANW | June 2, 2026 | ‘Watershed moment’ for cybersecurity; identity as primary defensive layer; 120% net retention for platformized customers | Elevated category awareness benefits GEN consumer acquisition; identity protection thesis validated | Positive |
FTNT | July 29, 2026 | Billings +33%, revenue +26%; AI driving security infrastructure modernization; service revenue trough behind them | Broad-based demand through July confirms healthy environment for GEN’s Q1 FY2027 period | Positive |
CHKP | July 30, 2026 | AI democratizing cyber attacks; subscription +12% YoY; product revenue -14% (go-to-market disruption) | AI threat democratization is a consumer demand tailwind; product weakness is company-specific | Mixed |
Key Takeaway: The only open-market buy since the May 7 earnings print was a small purchase by Director John Chrystal (3,000 shares, ~$80K) — a modest positive signal. The large sale by Director Ondrej Vlcek (100,000 shares, ~$2.5M) is notable in size but appears discretionary; no 10b5-1 plan was flagged. The absence of executive (CEO/CFO/COO) open-market selling is a mild positive.
Name | Title | Transaction Type | Value (Approx.) | Transaction Date | Note |
Vlcek Ondrej | Director | Open Market Sale | ~$2.5M (100,000 shares) | June 10, 2026 | Discretionary sale; no 10b5-1 plan flagged. Largest insider sale in the period. |
Chrystal John C | Director | Open Market Buy | ~$80K (3,000 shares) | June 4, 2026 | Only open-market buy in the period; modest but directionally positive signal. |
Vlcek Ondrej | Director | Tax Withholding (F-code) | ~$3.4K (128 shares) | June 1, 2026 | Shares withheld for tax obligation on vesting; routine, not discretionary. |
Derse Natalie Marie | CFO | Award Grant (A-code) | 135,118 shares | May 8, 2026 | Equity award grant (not an open-market purchase); routine compensation. |
Ko Bryan Seuk | COO, CLO & Secretary | Award Grant (A-code) | 135,118 shares | May 8, 2026 | Equity award grant (not an open-market purchase); routine compensation. |
Pilette Vincent | CEO, President & Chair | Award Grant (A-code) | 498,896 shares | May 8, 2026 | Equity award grant (not an open-market purchase); routine compensation. |
Source: Insider Transaction Data (SEC Form 4 filings). Open-market transactions only (Form 4 codes P/S/F). Award grants (A-code) are equity compensation and not indicative of directional conviction. The Director Vlcek sale of 100,000 shares on June 10 is the most notable transaction — it is a meaningful size relative to his remaining position (3.83M shares post-sale) but is not accompanied by a 10b5-1 plan designation, making it a discretionary sale. No executive-level (CEO/CFO/COO) open-market selling was observed in the period.